CD180 and systemic lupus erythematosus: Taken together, these results suggest that CD180 plays a critical role in regulating the activation of TLR7 and TLR9 pathways in macrophages and DCs, hinting that CD180 may be used as a potential therapeutic target for SLE treatment.